Fred Middleton Buys Shares of CALC
Fred Middleton purchased 248,972 shares of CALC, highlighting insider confidence.
Key Points
- Fred Middleton bought 248,972 shares of CALC on June 25, 2026, at $0.80 each, totaling $199,177.60.
- Shares of CALC traded near $0.82 on Monday, reflecting a recent insider buying spree.
- Other insiders, including the CEO, also bought shares, and analysts maintain a 'buy' rating.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Fred Middleton, an insider at CALC, made a significant purchase of 248,972 shares on June 25, 2026. The shares were acquired at an average price of $0.80 each, amounting to a total transaction value of $199,177.60. This move was not part of a pre-planned trading program.
Insider Buying and Selling at CalciMedica, Inc.
Fred Middleton wasn't the only insider buying shares of CALC. On the same day, other insiders, including CEO Rachel Leheny, Chief Medical Officer Sudarshan Hebbar, and Chief Business Officer Eric Roberts, also bought shares at the same price of $0.80. Notably, Robert Wilson acquired a substantial 1,182,621 shares, demonstrating strong insider interest.
Other Institutional Activity in CALC
Several institutional investors have also been active with CALC. Jane Street Group, LLC significantly increased its holdings by 159,312 shares, ending with 178,515 shares valued at $96,398. Vanguard Capital Management LLC opened a new position, acquiring 169,110 shares worth about $91,319. Renaissance Technologies LLC added 39,775 shares to its holdings, bringing its total to 128,075 shares valued at $69,161. Meanwhile, 180 Wealth Advisors, LLC boosted its stake by 94,650 shares, resulting in 126,500 shares valued at $68,310. Geode Capital Management, LLC increased its position by 23,595 shares, ending with 123,382 shares worth approximately $66,652.
CalciMedica, Inc. Stock Down 64.9%
Shares of CALC traded near $0.82 on Monday. While specific financial metrics like market cap and P/E ratio are not available, the stock's recent insider buying activity suggests confidence in its potential.
$CALC stock price
Daily closing prices, year to date. Not investment advice.
Analysts Set New Price Targets
On March 5, 2026, Oppenheimer maintained its 'buy' rating on CALC with a price target of $10. HC Wainwright & Co. has reiterated its 'buy' rating several times, with a target as high as $16. Lucid Capital Markets initiated coverage with a 'buy' rating and a $13 target in late 2024. Overall, the consensus remains positive with a strong 'buy' recommendation.
Bottom Line
Fred Middleton's recent purchase of CALC shares underscores significant insider confidence in the company's future. Such insider activity often attracts investor attention as a potential indicator of future performance. However, it's important to remember that these transactions are backward-looking and should be considered as part of a broader investment analysis.
Get CalciMedica, Inc. alerts
New 13F filings, insider trades, and analyst moves on $CALC, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.